292 related articles for article (PubMed ID: 22797919)
1. PKD2 and PKD3 promote prostate cancer cell invasion by modulating NF-κB- and HDAC1-mediated expression and activation of uPA.
Zou Z; Zeng F; Xu W; Wang C; Ke Z; Wang QJ; Deng F
J Cell Sci; 2012 Oct; 125(Pt 20):4800-11. PubMed ID: 22797919
[TBL] [Abstract][Full Text] [Related]
2. Aspirin Inhibits IKK-β-mediated Prostate Cancer Cell Invasion by Targeting Matrix Metalloproteinase-9 and Urokinase-Type Plasminogen Activator.
Shi C; Zhang N; Feng Y; Cao J; Chen X; Liu B
Cell Physiol Biochem; 2017; 41(4):1313-1324. PubMed ID: 28278500
[TBL] [Abstract][Full Text] [Related]
3. MUC1 protein induces urokinase-type plasminogen activator (uPA) by forming a complex with NF-κB p65 transcription factor and binding to the uPA promoter, leading to enhanced invasiveness of cancer cells.
Mori Y; Akita K; Tanida S; Ishida A; Toda M; Inoue M; Yashiro M; Sawada T; Hirakawa K; Nakada H
J Biol Chem; 2014 Dec; 289(51):35193-204. PubMed ID: 25371209
[TBL] [Abstract][Full Text] [Related]
4. BRMS1 contributes to the negative regulation of uPA gene expression through recruitment of HDAC1 to the NF-kappaB binding site of the uPA promoter.
Cicek M; Fukuyama R; Cicek MS; Sizemore S; Welch DR; Sizemore N; Casey G
Clin Exp Metastasis; 2009; 26(3):229-37. PubMed ID: 19165610
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase C induces motility of breast cancers by upregulating secretion of urokinase-type plasminogen activator through activation of AP-1 and NF-kappaB.
Sliva D; English D; Lyons D; Lloyd FP
Biochem Biophys Res Commun; 2002 Jan; 290(1):552-7. PubMed ID: 11779207
[TBL] [Abstract][Full Text] [Related]
6. Disruption of IkappaB kinase (IKK)-mediated RelA serine 536 phosphorylation sensitizes human multiple myeloma cells to histone deacetylase (HDAC) inhibitors.
Dai Y; Chen S; Wang L; Pei XY; Funk VL; Kramer LB; Dent P; Grant S
J Biol Chem; 2011 Sep; 286(39):34036-50. PubMed ID: 21816815
[TBL] [Abstract][Full Text] [Related]
7. RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.
Pulukuri SM; Gondi CS; Lakka SS; Jutla A; Estes N; Gujrati M; Rao JS
J Biol Chem; 2005 Oct; 280(43):36529-40. PubMed ID: 16127174
[TBL] [Abstract][Full Text] [Related]
8. Moscatilin Inhibits Metastatic Behavior of Human Hepatocellular Carcinoma Cells: A Crucial Role of uPA Suppression via Akt/NF-κB-Dependent Pathway.
Yu CL; Weng MS; Chen WC; Chien KT; Chi CW; Chung CH; Huang CW; Wang PC; Chen CC; Tsai AC; Liu SC; Wang SW
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805784
[TBL] [Abstract][Full Text] [Related]
9. β-Catenin and NF-κB cooperate to regulate the uPA/uPAR system in cancer cells.
Moreau M; Mourah S; Dosquet C
Int J Cancer; 2011 Mar; 128(6):1280-92. PubMed ID: 20473943
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of uPA and its receptor uPAR by 3,3'-diindolylmethane (DIM) leads to the inhibition of prostate cancer cell growth and migration.
Ahmad A; Kong D; Sarkar SH; Wang Z; Banerjee S; Sarkar FH
J Cell Biochem; 2009 Jun; 107(3):516-27. PubMed ID: 19330806
[TBL] [Abstract][Full Text] [Related]
11. Metformin inhibits the invasion of human hepatocellular carcinoma cells and enhances the chemosensitivity to sorafenib through a downregulation of the ERK/JNK-mediated NF-κB-dependent pathway that reduces uPA and MMP-9 expression.
Hsieh SC; Tsai JP; Yang SF; Tang MJ; Hsieh YH
Amino Acids; 2014 Dec; 46(12):2809-22. PubMed ID: 25245054
[TBL] [Abstract][Full Text] [Related]
12. Protein kinase Ds promote tumor angiogenesis through mast cell recruitment and expression of angiogenic factors in prostate cancer microenvironment.
Xu W; Qian J; Zeng F; Li S; Guo W; Chen L; Li G; Zhang Z; Wang QJ; Deng F
J Exp Clin Cancer Res; 2019 Mar; 38(1):114. PubMed ID: 30841931
[TBL] [Abstract][Full Text] [Related]
13. IL-1 beta induces urokinase-plasminogen activator expression and cell migration through PKC alpha, JNK1/2, and NF-kappaB in A549 cells.
Cheng CY; Hsieh HL; Sun CC; Lin CC; Luo SF; Yang CM
J Cell Physiol; 2009 Apr; 219(1):183-93. PubMed ID: 19097143
[TBL] [Abstract][Full Text] [Related]
14. Curcumin suppresses colon cancer cell invasion via AMPK-induced inhibition of NF-κB, uPA activator and MMP9.
Tong W; Wang Q; Sun D; Suo J
Oncol Lett; 2016 Nov; 12(5):4139-4146. PubMed ID: 27895783
[TBL] [Abstract][Full Text] [Related]
15. Osteopontin: it's role in regulation of cell motility and nuclear factor kappa B-mediated urokinase type plasminogen activator expression.
Das R; Philip S; Mahabeleshwar GH; Bulbule A; Kundu GC
IUBMB Life; 2005 Jun; 57(6):441-7. PubMed ID: 16012053
[TBL] [Abstract][Full Text] [Related]
16. Dimethylcelecoxib induces an inhibitory complex consisting of HDAC1/NF-κB(p65)RelA leading to transcriptional downregulation of mPGES-1 and EGR1.
Deckmann K; Rörsch F; Geisslinger G; Grösch S
Cell Signal; 2012 Feb; 24(2):460-467. PubMed ID: 21983014
[TBL] [Abstract][Full Text] [Related]
17. Iron stimulates urokinase plasminogen activator expression and activates NF-kappa B in human prostate cancer cells.
Ornstein DL; Zacharski LR
Nutr Cancer; 2007; 58(1):115-26. PubMed ID: 17571974
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic K-Ras and loss of Smad4 mediate invasion by activating an EGFR/NF-κB Axis that induces expression of MMP9 and uPA in human pancreas progenitor cells.
Bera A; Zhao S; Cao L; Chiao PJ; Freeman JW
PLoS One; 2013; 8(12):e82282. PubMed ID: 24340014
[TBL] [Abstract][Full Text] [Related]
19. CXCL1/GROα increases cell migration and invasion of prostate cancer by decreasing fibulin-1 expression through NF-κB/HDAC1 epigenetic regulation.
Kuo PL; Shen KH; Hung SH; Hsu YL
Carcinogenesis; 2012 Dec; 33(12):2477-87. PubMed ID: 23027620
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of angiogenesis and invasion by 3,3'-diindolylmethane is mediated by the nuclear factor-kappaB downstream target genes MMP-9 and uPA that regulated bioavailability of vascular endothelial growth factor in prostate cancer.
Kong D; Li Y; Wang Z; Banerjee S; Sarkar FH
Cancer Res; 2007 Apr; 67(7):3310-9. PubMed ID: 17409440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]